Category: DentalSyndicate content

Dental

Align Technology escapes shareholder lawsuit again

August 26, 2014 by Arezu Sarvestani

A California court again dismisses a shareholder lawsuit accusing Align Technology and its executives of insider trading and securities fraud.

Align Technology escapes shareholder lawsuit again

Align Technology (NSDQ:ALGN) announced this month that a California district court again dismissed a shareholder lawsuit, this time with prejudice.

Nobel Biocare sues Brazilian rival Neodent over dental implant

August 26, 2014 by Brad Perriello

Nobel Biocare sues Brazilian rival Neodent, alleging infringement of 2 patents covering its NobelActive dental implants by Neodent's Drive CM devices.

Nobel Biocare sues Brazilian rival Neodent over dental implant

Nobel Biocare's Q2 profits double as it fields buyout interest

August 21, 2014 by Brad Perriello

Nobel Biocare doubles its 2nd-quarter profits as it reportedly fields interest – and at least 1 offer worth $2.3 billion – from potential acquirers.

Nobel Biocare's Q2 profits double as it fields buyout interest

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Dentsply, Philips Healthcare land $39M in Pentagon deals

August 15, 2014 by Brad Perriello

Dentsply and Philips Healthcare land contracts worth a collective $39 million from the U.S. Defense Dept.

Dentsply, Philips Healthcare land $39M in Pentagon deals

Biolase ex-CEO demands answers following his board resignation

August 14, 2014 by Arezu Sarvestani

Ousted CEO Federico Pignatelli turns the spotlight on new leadership at his former company after resigning from the board of directors.

Biolase ex-CEO demands answers following his resignation

Former Biolase (NSDQ:BIOL) CEO Federico Pignatelli isn't ready to put down his dukes after dropping his seat on the company's board of directors.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Biolase ex-CEO Pignatelli ditches the board

August 7, 2014 by Arezu Sarvestani

Biolase's scorned former CEO Federico Pignatelli retires from the board of directors, saying that he was effectively forced out by hostilities from other members.

Biolase ex-CEO Pignatelli steps down from board

Former Biolase (NSDQ:BIOL) CEO Federico Pignatelli, who was removed from the corner office by a court order earlier this year, also walked away from the company's board of directors.

Ex-CEO Pignatelli backs down, but not out, in spat with Biolase

August 1, 2014 by Arezu Sarvestani

Scorned Biolase ex-CEO Federico Pignatelli withdraws his lawsuit as the company urges shareholders to welcome new leadership and deny his bid for re-election to the board.

Pignatelli backs down in spat with Biolase

Former Biolase (NSDQ:BIOL) CEO Federico Pignatelli agreed this week to withdraw his lawsuit against the dental devices maker, but he's still pursuing his personal investigation into the company's recent conduct.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp